These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7533367)

  • 1. Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients.
    Lang T; Krams SM; Villanueva JC; Cox K; So S; Esquivel C; Martinez OM
    Transplant Proc; 1995 Feb; 27(1):1146-7. PubMed ID: 7533367
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
    Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
    Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
    [No Abstract]   [Full Text] [Related]  

  • 3. Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression.
    Gaweco AS; Otto G; Otto HF; Meuer S; Geisse T; Hofmann WJ
    Transplant Proc; 1995 Feb; 27(1):1152-4. PubMed ID: 7533370
    [No Abstract]   [Full Text] [Related]  

  • 4. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early graft function in liver transplantation patients.
    Ericzon BG
    Transplant Proc; 1994 Dec; 26(6):3276-8. PubMed ID: 7527965
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of combined immune therapy on survival and Th1/Th2 cytokine balance in rat orthotopic liver transplantation.
    Cao H; Liu H; Wu ZY
    Chin Med J (Engl); 2007 Oct; 120(20):1809-12. PubMed ID: 18028776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation.
    Bathgate AJ; Lee P; Hayes PC; Simpson KJ
    Liver Transpl; 2000 Nov; 6(6):721-7. PubMed ID: 11084058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of cytokine expression in rat liver allograft rejection compared to allograft tolerance.
    Sun J; Matsumoto Y; McCaughan GW; Gallagher ND; Sheil AG; Bishop GA
    Transplant Proc; 1992 Oct; 24(5):2309. PubMed ID: 1413072
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts.
    Lang T; Krams SM; Martinez OM
    Transplantation; 1996 Sep; 62(6):776-80. PubMed ID: 8824477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low level of interleukin 10 synthesis during liver allograft rejection.
    Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
    Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats.
    Chen Y; Chen J; Liu Z; Liang S; Luan X; Long F; Peng Y; Yan L; Gong J
    Transplant Proc; 2008 Oct; 40(8):2691-5. PubMed ID: 18929837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients.
    Gras J; Wieërs G; Vaerman JL; Truong DQ; Sokal E; Otte JB; Délépaut B; Cornet A; de Ville de Goyet J; Latinne D; Reding R
    Liver Transpl; 2007 Mar; 13(3):426-33. PubMed ID: 17318867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cytokine expression in an animal model of acute liver allograft rejection.
    Egawa H; Martinez OM; Quinn MB; So S; Esquivel CO; Krams SM
    Transplant Proc; 1995 Feb; 27(1):505-6. PubMed ID: 7879079
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologic monitoring of the efficacy of immunosuppression in liver transplant patients.
    Farges O; Buffello D; Swercz B; deGroote D; Bismuth H
    Transplant Proc; 1995 Aug; 27(4):2516-8. PubMed ID: 7652911
    [No Abstract]   [Full Text] [Related]  

  • 20. Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection.
    Baan CC; Metselaar HJ; Mol WM; Tilanus HW; IJermans JM; Zondervan PE; Schalm SW; Niesters HG; Weimar W
    Clin Transplant; 1996 Dec; 10(6 Pt 1):542-9. PubMed ID: 8996776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.